N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
- PMID: 30127713
- PMCID: PMC6088236
- DOI: 10.3389/fnins.2018.00536
N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
Abstract
This report provides a historical overview of research concerning the endogenous hallucinogen N, N-dimethyltryptamine (DMT), focusing on data regarding its biosynthesis and metabolism in the brain and peripheral tissues, methods and results for DMT detection in body fluids and brain, new sites of action for DMT, and new data regarding its possible physiological and therapeutic roles. Research that further elaborates its consideration as a putative neurotransmitter is also addressed. Taking these studies together, the report proposes several new directions and experiments to ascertain the role of DMT in the brain, including brain mapping of enzymes responsible for the biosynthesis of DMT, further studies to elaborate its presence and role in the pineal gland, a reconsideration of binding site data, and new administration and imaging studies. The need to resolve the "natural" role of an endogenous hallucinogen from the effects observed from peripheral administration are also emphasized.
Keywords: N; N-dimethyltryptamine; brain; hallucinogen; neurotransmitter; psychedelic.
Figures



Similar articles
-
A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.J Neural Transm (Vienna). 2013 Sep;120(9):1295-303. doi: 10.1007/s00702-013-1024-y. Epub 2013 Apr 26. J Neural Transm (Vienna). 2013. PMID: 23619992 Review.
-
Neuropharmacology of N,N-dimethyltryptamine.Brain Res Bull. 2016 Sep;126(Pt 1):74-88. doi: 10.1016/j.brainresbull.2016.04.016. Epub 2016 Apr 25. Brain Res Bull. 2016. PMID: 27126737 Free PMC article. Review.
-
N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk.Alzheimers Res Ther. 2024 May 1;16(1):95. doi: 10.1186/s13195-024-01462-3. Alzheimers Res Ther. 2024. PMID: 38693554 Free PMC article.
-
Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT.Psychopharmacology (Berl). 2022 Jun;239(6):1749-1763. doi: 10.1007/s00213-022-06065-0. Epub 2022 Jan 22. Psychopharmacology (Berl). 2022. PMID: 35064294 Free PMC article. Review.
-
Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.J Psychopharmacol. 2007 May;21(3):312-20. doi: 10.1177/0269881107077734. J Psychopharmacol. 2007. PMID: 17591658 Clinical Trial.
Cited by
-
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.Cell Mol Life Sci. 2024 Sep 10;81(1):395. doi: 10.1007/s00018-024-05353-6. Cell Mol Life Sci. 2024. PMID: 39254764 Free PMC article. Review.
-
Key Characteristics and Development of Psychoceuticals: A Review.Int J Mol Sci. 2022 Dec 12;23(24):15777. doi: 10.3390/ijms232415777. Int J Mol Sci. 2022. PMID: 36555419 Free PMC article. Review.
-
The morphological and functional characteristics of the pineal gland.Med Pharm Rep. 2019 Jul;92(3):226-234. doi: 10.15386/mpr-1235. Epub 2019 Jul 31. Med Pharm Rep. 2019. PMID: 31460502 Free PMC article. Review.
-
A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers.Front Pharmacol. 2021 Nov 25;12:760671. doi: 10.3389/fphar.2021.760671. eCollection 2021. Front Pharmacol. 2021. PMID: 34912222 Free PMC article.
-
Pharmacokinetics of N,N-dimethyltryptamine in Humans.Eur J Drug Metab Pharmacokinet. 2023 May;48(3):311-327. doi: 10.1007/s13318-023-00822-y. Epub 2023 Apr 22. Eur J Drug Metab Pharmacokinet. 2023. PMID: 37086340 Free PMC article. Clinical Trial.
References
-
- Axelrod J. (1961). Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science 134, 343–344. - PubMed
-
- Barchas J. D., Elliott G. R., Do-Amaral J., Erdelyi E., O'Conner S., Bowen M., et al. . (1974). Tryptolines formation from tryptamines and 5-MTHF by human platelets. Arch. Gen. Psychiat. 31, 862–867. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous